Irritative toxic rhinitis is a nasal disorder induced by chemical compounds like ozone, formaldehyde, nickel, chrome, solvents and tobacco smoke. These noxious stimuli may have effects on the nasal innervation leading to a cascade of neuro-immune interactions and an augmentation of the symptoms. Here we examined changes in the neuropeptide content of mucosal parasympathetic, sympathetic and sensory nerves of patients with toxic rhinitis caused by chronic cigarette smoke exposure. Semiquantitative immunohistochemistry using antibodies against calcitonin gene-related peptide (CGRP), substance P (SP), neuropeptide tyrosine (NPY), and vasoactive intestinal peptide (VIP) was carried out on cryostat sections of human nasal mucosa obtained from normal subjects and patients with toxic rhinitis and revealed significant differences between both groups. Toxic rhinitis patients had significantly elevated expression scores for VIP (2.83 ± 0.31 vs 1.27 ± 0.47 control group) and NPY (3.17 ± 0.31 vs 0.91 ± 0.37 control group) revealing an increase of mediators in distinct subpopulations of airway nerves. In summary, the present studies indicate a differential participation of subclasses of mucosal nerves in the pathophysiology of toxic rhinitis. Airway innervation may have a major role in the pathophysiology of toxic rhinitis associated with chronic cigarette smoke exposure.
INTRODUCTION
Rhinitis can be classified into allergic and nonallergic types. Whereas allergic rhinitis may be subdivided into a seasonal (25) and perennial disease (4, 30) , nonallergic rhinitis is considered to be a separate disease category that includes a variety of types (33) . Nonallergic rhinitis is a well-known disease of the upper airways, that presents with the symptoms of rhinorrhea, nasal congestion, and pruritus (24) . Its incidence has only been revealed recently: The National Rhinitis Task Force study reported that nonallergic rhinitis probably affects as many as 17 million Americans. Also it was assumed that approximately 22 million people suffer from a combination of nonallergic rhinitis and allergic diseases (mixed rhinitis). Both forms, mixed and nonallergic rhinitis occur more frequently in adults, may be more common in female patients and are more likely to be perennial than seasonal (32) .
Although the acute forms of nonallergic rhinitis are mainly caused by infectious diseases, chronic nonallergic rhinitis is often diagnosed as toxic rhinitis and vasomotoric rhinitis, which is distinct from toxic rhinitis and only diagnosed after the exclusion of all other rhinitis types (17) . Toxic rhinitis, which is the focus of the present study, is a nasal disorder induced by chemical noxious substances such as ozone, nickel, chrome, solvents, and tobacco smoke. Based on controlled trials or approval by the FDA, topical nasal steroids and azelastine are efficacious treatments for nonallergic rhinitis (32) .
Recently it has been shown that the airway innervation may play a role in allergic (8) and nonallergic airway diseases (18) and protects against inhaled toxicants (35) . Here we examined changes of neuropeptide contents in the nasal mucosal innervation of patients with toxic rhinitis.
MATERIALS AND METHODS

Patients
For the present studies, tissues from a total number of 17 female and male individuals were recruited after having obtained informed consent by each subject and approval by the Ethics Committee ( Table 1 ). The patients were evaluated by rhinological examination and their medical history. Also a series of further examinations was performed to exclude allergic or other nonallergic diseases such as vasomotor rhinitis. These examinations consisted or prick test, rhinomanometric test, routine nasal smear with cytology, and saccharin-tests and nasal provocation or serum IgE-counts by radio immunosorbens assay (RAST). Patients with seasonal or perennial allergic rhinitis, vasomotor rhinitis or aspirinsensitive rhinitis were excluded.
Tissue Sampling
The biopsies of inferior nasal turbinate mucosa were obtained from a control group of 11 nonrhinitic patients and 6 patients with toxic rhinitis during routine surgical interventions (rhinoplasty). The biopsies were fixed by immersion using buffered picric acid-paraformaldehyde (39) at room temperature. A fixation period of 4 hours was followed by repeated rinsing steps in phosphate-buffered saline (PBS) and cryoprotection using 18% saccharose (1604, Riedel-de 326 Haen AG, D-Seelze) containing phosphate buffer overnight at 4 • C. All tissues were finally frozen in liquid nitrogen-cooled isopentane and stored at −80 • C.
Immunohistochemistry for Neuropeptides
For immunohistochemical detection of neuropeptides a previously established protocol was applied (10): Inferior turbinate nasal mucosa biopsies were processed to serial sections using a cryostat. The sections were then mounted onto glass slides that were precoated with chromalaun (11) . Frozen sections were allowed to warm to room temperature for 1 hour and were then washed in PBS for 3 × 5 min. Nonspecific labeling was blocked by coating with 0.1 M phosphate buffer containing 1% bovine serum albumin and 10% normal swine serum for 1 hour at room temperature. After preincubation to prevent non-specific background labeling, the sections were rinsed in PBS 2 × 5 min and incubated with different primary antibodies directed against Protein Gene Product 9.5 and the different neuropeptides (Table 2 ) overnight at 4 • C. After incubation, removal of the incubation solution by negative air pressure and repeated washing steps with PBS, the sections were subsequently incubated with specific secondary antibodies and tertiary reagents ( Table 2 ). The slides were then washed, mounted with carbonate-buffered glycerol (pH 8.6) and examined with fluorescence microscopy. Normal rabbit IgG and omission of primary or secondary antibodies were used as negative control and negative controls were matched to the immunoglobulin concentration of the primary antibodies. The amount of neuropeptide content in mucosal nerve fibers was graded semiquantitatively using previously established scoring systems (7, 22) . Immunofluorescence staining was graded from 0 to 4, with 0 representing no staining, grade 1 representing focal staining, and grades 2, 3, and 4 representing diffuse weak, moderate, and strong staining, respectively. All analyses, including immunohistochemical grading, were performed in a blind fashion by 2 investigators with the grades of the 2 investigators averaged for the final grade.
Eosinophil and Mast Cell Quantification
A histological examination of tissue morphology was performed using previously described standard hematoxylineosin staining procedures (9, 13) . Then the identification of mast cells and eosinophils was performed with immunohistochemical or conventional histochemical techniques: For eosinophil identification, either giemsa staining or eosinophil cationic protein (ECP) clone EG1 and EG2 antibodies were used ( Table 2 ). Mast cells were examined using either toluidine blue or anti-human mast cell tryptase antibody and antihuman immunoglobuline E (IgE) antibody ( Table 2) .
After rinsing in PBS, endogenous peroxidase activity was blocked by incubating the slides in 0.3% (wt/vol) hydrogen peroxide in 70% methanol for 30 min. Nonspecific labeling was blocked by incubation with preincubation serum (0.1 M phosphate buffer containing 1% bovine serum albumin and 10% normal swine serum) for 1 hour at room temperature (12) . After washing in PBS the tissues were incubated with the primary antibodies. Overnight incubation was followed by and repeated washing steps with PBS, the immunostaining was detected with biotinylated horse anti-mouse IgG (diluted 1: 75 in preincubation serum, Vectastain ABC, Vector Laboratories, Burlinghame, USA). As control of the specificity of the mast cell and eosinophil markers, parallel sections were stained with toluidine blue and giemsa and confirmed specificity.
RESULTS
Tissue Morphology and Distribution of Eosinophils and Mast Cells
In comparison to nasal mucosa of non-rhinitic subjects, the tissues of toxic rhinitis patients revealed characteristic features of nasal mucosa inflammation: There was metaplastic epithelium present ( Figure 1 ) and an inflammatory cell influx. These cells were found to be neutrophils as found within the nasal smear ( Figure 2B ) and mast cells and eosinophils. Staining for eosinophil-specific markers revealed the presence of eosinophils in the mucosa. Also, using Toluidine blue-staining and the immunohistochemical mast cell markers tryptase and IgE (Figure 2A ), mast cell infiltration was found with a presence predominantly around small blood vessels, glands and in the subepithelial layer. The numbers of both cell types were not increased but single mast cells appeared to be degranulated.
Nerve Fiber Distribution in Normal Nasal Mucosa
PGP 9.5 immunoreactive nerve fibers were found as branching networks in the subepithelial layer and here especially around blood vessels. VIP-immunoreactivity was distributed mainly to nerve fibers near submucosal glands and blood vessels. NPY-immunohistochemistry demonstrated staining of NPY expression in fibers predominantly around TOXICOLOGIC PATHOLOGY blood vessels. Immunohistochemistry for CGRP revealed that this neuropeptide was expressed in nerve fibers around sinusoids, blood vessels, and glands. Also, SP-immunoreactive nerves were present below the epithelium and around glandular structures and vessels ( Figure 3 ).
Quantification of Nerve Fibers in Toxic Rhinitis
Similar to the results obtained in tissues of normal human nasal mucosa, staining of toxic rhinitis biopsies for PGP 9.5 lead to the visualization of fibers which were present underneath the respiratory epithelium, around blood vessels and in the lamina propria. The immunohistochemical staining for NPY, CGRP, VIP and SP-positive fibers also showed a cellular distribution that was qualitatively similar to controls. Using a previously established scoring protocol, major quantitative differences in the neuropeptide content of mucosal nerve fibers were present between toxic rhinitis patients and control subjects. In the control group of nonrhinitic subjects scores (means ± standard error of the mean) of 1.55 ± 0.39 for CGRP, 1.27 ± 0.47 for VIP 1, 1.73 ± 0.41 for SP, and 0.91 ± 0.37 for NPY were found. In contrast, in the toxic rhinitis group, the scores were significantly elevated for NPY (3.17 ± 0.31, p < 0.001) and VIP (2.83 ± 0.31, p < 0.04) and there was a tendency for SP to also be elevated (2.83 ± 0.31) (Figure 4 ). 
DISCUSSION
The predominant symptoms of toxic rhinitis are sneezing, rhinorrhea, nasal obstruction and especially in the chronic phase a dryness of the nasal mucosa (6, 38) . These effects may be modulated by mucosal innervation and therefore the present study was carried out to determine changes in the neuropeptide contents of mucosal nerve fibers. After characterization of inflammatory changes, which were most probably caused by neutrophils as mast cell and eosinophil numbers did were not significantly increased, semiquantitative immunohistochemistry was carried out and changes in the nasal mucosal innervation of patients with cigarette smoke associated toxic rhinitis were assessed. We found a differential expression of neuropeptides in nerve fibers as visualized with a panel of different antibodies which were raised against the general neuronal marker PGP 9.5, and the neuropeptides CGRP, SP, NPY, and VIP.
All presently examined tissue derived from toxic rhinitis due to chronic tobacco smoke inhalation. Tobacco smoke can be divided into two main components: the vaporous phase containing substances such as aldehydes, acrolein, phenols, nitrogen oxide species, and the particle phase consisting of nicotine and tar (34) . The different substances of the vaporous phase can lead to vasodilation, plasma extravasation and glandular secretion via the stimulation of capsaicin-sensitive sensory C-fibers (1, 26, 27, 29) . Chronic exposure to tobacco smoke also leads to nasal and bronchial hyperreactivity (5, 19) , which has been previously been demonstrated to be mediated by neuromediators. Here we were able to show Vol. 31, No. 3, 2003 NEUROPEPTIDES AND TOXIC RHINITIS 329 significantly increased levels of VIP-and NPY-expression in nerve fibers. This finding indicates that major changes in the composition of mucosal nerves occur in toxic rhinitis. There was also a tendency of increase in substance P expression (SP). SP is a tachykininergic neuropeptide which is synthesized in perikarya of neurons which mainly project as nonmyelinized sensory nerve fibers to the human nasal mucosa (3) . As shown here and previously, SP-immunoreactive nerve fibers are located around glands and blood vessels, between smooth muscle myocytes and subepithelially. Its biological effects in upper airways consist of plasma extravasation, vasodilatation, and increased glandular secretion and mucociliary clearance (2, 21, 31) .
Recently, a study was carried out to investigate the effects of environmental irritants on nasal mucosa innervation using an animal model and toluene diisocyanate (TDI) (15) . This compound can induce occupational asthma (37) in about 10% of workers involved in the production of plastics, adhesives, foams, surface coatings, and polyurethane polymers (20) . After TDI exposure of rats, SP-immunoreactive nerve fiber density was significantly increased in nasal epithelium. Also, the proportion of microsphere-labeled cell bodies expressing high levels of SP-immunoreactivity was increased at 48 and 72 hours after TDI exposure (15) . The present study demonstrated a similar tendency in increase of SP expression in mucosal nerve fibers of human toxic rhinitis and indicates similarities in the pathophysiology of these two irritants. Parallel to the previous examinations that directly showed neuronal plasticity of trigeminal sensory ganglia after TDI exposure in rats (15) , a change in the neurochemical nature of human sensory trigeminal neurons may be assumed after tobacco exposure. The activation of SPcontaining sensory nerves may also lead to sympathetic or parasympathetic axon reflexes (3) . In this respect, the present studies demonstrated increased VIP expression in mucosal nerves. Vasoactive intestinal polypeptide (VIP) is one of the most abundant, biologically active peptides found in the upper and lower respiratory tract (28) . VIP is neurotransmitter of the inhibitory nonadrenergic noncholinergic airway nervous system and influences many aspects of airway biology. Next to its prominent bronchodilatory in the lower airways, VIP potently relaxes mucosal vessels. The precise role of VIP in the pathogenesis of rhinitis is still uncertain (14) . Increased levels of VIP as shown here may result in additional hypersecretion that occurs in toxic rhinitis. As SP, VIP, and NPY-containing nerve fibers belong to different subclasses of airway nerves, a participation not only of sensory nerves but also of parasympathetic and sympathetic nerves can be assumed.
Cigarette smoke has also been reported to be a mediator of mast cell activation (36) . This effect has also been shown for SP, which induces a degranulation of mast cells with consecutive synthesis of cytokines and leukocyte chemotaxis and to a production of inflammatory cytokines (IL-6) by monocytes (23) . In the present case of tobacco smoke induced toxic rhinitis, cigarette smoke may have either directly induced mast cell degranulation or exerted this effect via increased levels of SP-immunoreactive nerve fibers as shown here. Both mechanisms may exist, as smokers have higher serum IgElevels than nonsmokers (16) and in animal models, cigarette smoke solution was shown to activate mast cells, resulting in a release of histamine and tryptase (36) .
In summary, the present studies indicate a variation of neuropeptide-contents in nasal mucosa nerve fibers of tobacco smoke-associated toxic rhinitis patients. Therefore, a participation of the autonomous innervation in toxic rhinitis may be assumed.
